News

Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy

(Bloomberg) -- Pharmaceutical stocks declined as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department of Health and Human Services, potentially elevating a prominent vaccine skeptic and broader industry critic to a top role on health policy.Most Read from BloombergUnder Trump, Prepare for New US Transportation PrioritiesZimbabwe City of 700,000 at Risk of Running Dry by Year-EndSaudi Neom Gets $3 Billion Loan Guarantee From Italy Export Credit Agency SaceThe

Oppenheimer Signals Buy on 2 Data Storage Stocks — Here’s Why They’re Bullish

2024 is heading into its final stretch, and it’s natural now to try to figure out what trends will support the stock markets going forward. One key factor that we can’t ignore is the continuing boom in artificial intelligence. Advances in AI technology have boosted the tech sector generally – but those gains have been especially strong in AI-related stock segments such as semiconductor chips, data center services, and data storage. The last in particular deserves a closer look. Data is a main be

These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts

The year is winding down, but the bull markets are still charging ahead, getting a boost from improved sentiment after the presidential election. While the next few months will be a time of transition, a few things are likely. The Trump administration is expected to pursue a far looser regulatory policy than the outgoing Biden government. Plans for individual tax cuts are projected to drive consumer spending, while reductions in corporate taxes could deliver an immediate boost to earnings. While